All In Biotech

Drug Trial Radar · NCT05763121

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma

Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingPhase 3. Randomized with 1,061 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,061

Actual

Start

Jan 30, 2023

Primary completion

Dec 8, 2025

Study completion Dec 8, 2025

Sponsor

Lead sponsor
Areteia TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of dexpramipexole as an adjunctive oral therapy in participants with inadequately controlled asthma with an eosinophilic phenotype and a history of asthma exacerbations.

Conditions

  • Eosinophilic Asthma
  • Asthma; Eosinophilic
  • Asthma

Interventions

  • Dexpramipexole DihydrochlorideDrug

    oral administration of dexpramipexole tablet

  • PlaceboDrug

    oral administration of placebo tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Annualized rate of severe asthma exacerbations over 52 weeks.Time frame: Day 1 (baseline, pre-dose) through Week 52

Locations

401 sites in 20 countries. Site status is shown where the registry gives one.

  • Research Site 20001-374

    Bakersfield, California

  • Research Site 20001-440

    La Palma, California

  • Research Site 20001-062

    Newport Beach, California

  • Research Site 20001-043

    Newport Beach, California

  • Research Site 20001-380

    Redding, California

  • Research Site US-20001-488

    San Diego, California

  • Research Site 20001-003

    West Covina, California

  • Research Site 20001-419

    Westminster, California

  • Research Site 20001-048

    Aventura, Florida

  • Research Site 20001-005

    Brandon, Florida

  • Research Site 20001-051

    Brandon, Florida

  • Research Site 20001-029

    Coral Gables, Florida

  • Research Site 20001-350

    Gainesville, Florida

  • Research Site 20001-014

    Green Acres, Florida

  • Research Site 20001-054

    Hialeah, Florida

  • Research Site 20001-067

    Hialeah, Florida

  • Research Site 20001-020

    Homestead, Florida

  • Research Site 20001-015

    Kissimmee, Florida

  • Research Site 20001-002

    Kissimmee, Florida

  • Research Site 20001-086

    Loxahatchee Groves, Florida

  • Research Site 20001-066

    Miami, Florida

  • Research Site 20001-001

    Miami, Florida

  • Research Site 20001-059

    Miami, Florida

  • Research Site 20001-026

    Miami, Florida

  • Research Site 20001-065

    Miami, Florida

  • Research Site 20001-024

    Miami, Florida

  • Research Site 20001-069

    St. Petersburg, Florida

  • Research Site 20001-004

    Tampa, Florida

  • Research Site 20001-075

    Augusta, Georgia

  • Research Site 20001-018

    Columbus, Georgia

  • Research Site 20001-459

    Sugar Hill, Georgia

  • Research Site 20001-090

    Berwyn, Illinois

  • Research Site 20001-476

    Chicago, Illinois

  • Research Site 20001-358

    Normal, Illinois

  • Research Site 20001-135

    River Forest, Illinois

  • Research Site 20001-403

    Skokie, Illinois

  • Research Site 20001-036

    Elwood, Indiana

  • Research Site 20001-044

    Evansville, Indiana

  • Research Site 20001-021

    Iowa City, Iowa

  • Research Site 20001-019

    Owensboro, Kentucky

Showing 40 of 401 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.